Last reviewed · How we verify

NCT04026217

Diaphragm Ultrasound as a Powerful Tool in Managing Acute Hypoxemic Respiratory Failure in Hematological Patients

Suspended Last updated 31 January 2024
What this trial tests

trial in Respiratory Failure in 30 participants. Suspended.

Timeline
27 May 2019
Primary endpoint
27 December 2021
31 January 2024

Quick facts

Lead sponsorAzienda Sanitaria-Universitaria Integrata di Udine
StatusSuspended
Study typeOBSERVATIONAL
Enrollment30
Start date27 May 2019
Primary completion27 December 2021
Estimated completion31 January 2024
Sites1 location across Italy

Conditions studied

Sponsor

Azienda Sanitaria-Universitaria Integrata di Udine — full company profile →

Who can join

18 and older, any sex, with Respiratory Failure or Diaphragm Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute hypoxemic respiratory failure due to parenchymal disfunction is one of the main complications of immunocompromised hematological patients. Mechanical ventilation is frequently needed and diaphragm activity has to be assessed not to worsen ventilator-induced lung injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other Azienda Sanitaria-Universitaria Integrata di Udine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing